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A cDNA encoding a human liver UDPGT (HLUG 25) transcribed and translated in vitro showed that the encoded pro- 
tein was synthesized as a precursor and was cleaved and glycosylated when dog pancreatic microsomes were present dur- 
ing translation. The UDP(3T cDNA was transiently expressed in mammalian cell culture (COS-7 cells) resulting in the 
biosynthesis ofa polypeptide of 52 kDa. This expressed UDPGT glycoprotein catalysed the glucuronidation fhyodcoxy- 
cholic acid forming an ether glucuronide. These results suggest that this UDPGT isoenzyme may be responsible for the 
glucuronidation f6~-hydroxy bile acids in human liver. 
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1. INTRODUCTION 
Bile acid glucuronides are excreted in urine of 
healthy humans where they represent 12 to 36°70 of 
the total daily bile acid excretion [1]. Moreover an 
increase in the rate of glucuronides formed, com- 
pared to glucosides, occurs in certain hepatobiliary 
diseases [2,3]. A major proportion of the normal 
bile acids found in urine are hydroxylated at C-6 of 
the B ring of the steroid, and 3a,6a-dihydroxy-Sfl- 
cholanic acid (hyodeoxycholic acid) has recently 
been identified as a quantitatively important bile 
acid [1]. Among the bile acids orally administered 
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to healthy subjects, hyodeoxycholic acid can be 
distinguished by its high rate of glucuronidation 
and urinary excretion. 
The high UDP-glucuronosyltransferase 
(UDPGT, EC 2.4.1.17) activity in vitro towards 
hyodeoxycholic acid found in human liver and 
kidney microsomes i in good agreement with in 
vivo data and may explain the rapid clearance of 
hyodeoxycholic a id in urine [4-6]. Consequently 
it became apparent that glucuronidation of bile 
acids at the 6~-hydroxy position, rather than the 
3a-hydroxyl group represented a major pathway 
of bile acid glucuronidation i man [1]. 
In this paper, we present evidence that a cloned, 
expressed human UDPGT isoenzyme catalyses the 
ether glucuronidation of bile acids. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Hyodcoxycholic acid (3ot,6tr-dihydroxy-5~-cholan-24-oic ac- 
id), chenodeoxycholic acid (3tr,7ot-dihydroxy-Sfi'-cholan-24- oic 
acid), ursodcoxycholic a id (3tr,TB-dihydroxy-Sfl-cholan-24- oic 
acid), cholic acid (3¢r,7tr, 12tr-trihydroxy-Sfi'-cholan-24-oic acid) 
and lithocholic acid (3ot-hydroxy-SB-cholan-24-oic acid) were 
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kindly provided by Dr P. Ross (Ninewells Hospital, Dundee, 
Scotland). Testosterone, androsterone, oestrone, 1-naphthol 
and 2-naphthol were from Sigma (Poole, Dorset, England). 
2.2. Cloning of full-length cDNA HLUG25 
A eDNA clone (HLUG25) encoding the complete sequence of 
a human liver UDPGT was isolated in this laboratory from a 
Agtl I human liver eDNA library as previously described [7]. 
2.3. Expression of HLUG25 in transfected COS-7 cells 
The partial EcoRI digest of HLUG25 eDNA was subcloned 
in a modified Bluescript vector including flanking HindlIl sites. 
The eDNA fragment including the flanking HindllI sites of this 
vector was ligated into the HindllI site of the expression vector 
pKCRH2. The correct and opposite orientations of HLUG25 
eDNA with respect o the SV40 early gene transcription pro- 
moter in pKRH2 were determined by restriction mapping of 
plasmid minipreps before large scale DNA preparation of the 
(+) and ( - )  recombinant plasmids., 
COS-7 cells were maintained in Dulbecco's minimal essential 
medium (DMEM) containing 10070 (v/v) foetal calf serum, 
2 mM glutamine and 50 U/ml penicillin/streptomycin. The 
recombinant plasmid (30/~g/140 mm dish) was transfected to 
70°70 confluent cells by the CaPOa/glycerol shock procedure 
[8]. Hepes buffer, pH 7.2 (50 mM), was added to the medium 
to maintain constant pH. Cells were harvested 2 days after 
transfection, washed in 138 mM NaC1/2.7 mM KCI/1.5 mM 
potassium dihydrogen phosphate/8 mM disodium hydrogen 
phosphate/HCl, pH 7.4 (PBS) and pelleted by centrifugation at
1000 × g for 15 min. Disruption of the cells was achieved by a 
three times freezing (-50°C)-thawing (37°C) cycle before 
storage at - 80°C. 
2.4. Labelling and immunoprecipitation 
At 72 h post-transfection COS-7 cells were washed, in- 
cubated 1 h in methionine free DMEM medium and labelled for 
4 h with 50/~Ci of L-[aSS]methionine (1420 Ci/mmol). Cells 
were rinsed twice in ice-cold PBS, harvested and centrifuged at 
1500 × g for 15 min. The pellets were suspended, washed and 
pelleted again. The pellet was solubilised with 0.5070 (w/v) deox- 
ycholate, 1070 Triton X-100, 0.1070 (w/v) SDS in 10 mM Tris- 
HCI, pH 7.4, by gentle hand homogenisation. The mixture was 
centrifuged at 16000 x g and the supernatant was incubated 
with preimmune serum and with sheep anti-rat UDPGT an- 
tiserum as previously described, except hat incubations with 
antiserum were overnight in ice [9]. The final products were 
analysed by SDS gel electrophoresis on7.5070 gels [10] followed 
by fluorography [11]. 
2.5. In vitro transcription~translation of HLUG25 cDNA 
The partial EcoRI digest of HLUG25 eDNA was ligated into 
the EcoRI site of the plasmid Gemini 1 (Promega Biotec, 
Madison, WI, USA). After transformation i to E. coli JM 101, 
plasmids containing inserts in the correct orientation for 
transcription of a functional RNA and those in the reverse 
orientation were isolated and linearised with EcoRV. RNA was 
synthesized in vitro by T7 RNA polymerase, capped using 
GS'pppS' and added to a messenger-dependent r ticulocyte 
lysate system with 15/~Ci of L-[35S]methionine in the presence 
or absence of dog pancreas microsomes [12,13]. lm- 
munoprecipitation a d SDS-PAGE of the translation products 
were carried out as described above. 
2.6. UDPGT activity assay in the transfected COS-7 cells and 
human microsomes 
The cell homogenate (protein content measured according to 
the procedure of Lowry et ai. [14]) was assayed for UDPGT ac- 
tivities by a thin-layer chromatographic method as previously 
described [15]. Incubation conditions were the same as in [16], 
except hat the reaction was performed using 18/~M (8/zM ~4C- 
labelled, 0.15/LCi) UDP-glucuronic acid, 0.5 mM aglycone and 
0.1 mg cell homogenate protein in 100mM Tris/maleate, 
10 mM MgC12, 2 mg/ml bovine serum albumin buffer, pH 7.0, 
in the presence of egg lecithin liposomes (0.2 mg/mg protein) to 
facilitate access of the bile acids to the enzyme. The enzyme 
reaction was stopped after 60 min at 37°C. This low concentra- 
tion of UDP-glucuronic acid was used to improve the sensitivity 
of the assay by allowing a greater proportion of the radioactive 
label to be incorporated into the glucuronides synthesized (limit 
of detection: 0.1 pmol/min per mg protein). The assay occurred 
at linear rates under these conditions. Human liver microsomes 
were prepared as previously described [17] and protein content 
measured according to Lowry et al. [14]. Glucuronidation f 
the various ubstrates in human liver microsomes was evaluated 
as described above except protein content was 0.05 mg per 
assay and incubation time was reduced to 15 min. 
3. RESULTS AND DISCUSSION 
3.1. Expression o f  UDPGTprote in  in vitro and in 
COS-7 cells in culture 
The human l iver HLUG25 eDNA (2104 base- 
pairs long)  [7] was expressed in both  in v ivo  and in 
v i t ro  systems. HLUG25-RNA was t ranscr ibed 
f rom a Gemin i  vector  and,  when t rans lated in 
v i t ro ,  p roduced  a 53 kDa po lypept ide  ( f ig . lA ,  
lanes 1 and 2). When dog pancreat ic  mic rosomes  
were added to the t rans lat ion  mixture  pr imed with 
HLUG25,  a h igher  rate o f  t rans lat ion  occur red  as 
can be seen by compar i son  o f  the rad io labe l led 
t rans la t ion  products  in lanes 1 and 3 ( f ig . lA ) ,  
wh ich  cor respond to the same exposure  t imes. The 
compar i son  o f  lanes 1 and 2 with lane 3 revealed 
two add i t iona l  faster migrat ing  po lypept ides  o f  50 
and 52 kDa,  when the t rans lat ion  was per fo rmed 
in the presence o f  dog pancreat ic  mic rosomes .  
They  cor respond to the c leaved prote in  and 
c leaved plus g lycosylated prote in ,  respect ively,  in 
agreement  with the presence o f  a signal sequence 
and one potent ia l  N -g lycosy la t ion  site ident i f ied 
f rom the nuc leot ide  sequence o f  the eDNA [7]. 
Rad io labe l led  prote ins immunoprec ip i tab le  with 
speci f ic  ant i -UDPGT ant isera cou ld  on ly  be seen 
wi th  HLUG25-RNA in the correct  o r ientat ion  (not 
shown) .  The  other  minor  products  which were 
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Fig. 1. Expression of HLUG25 cDNA in vitro and in vivo. (A) 
HLUG25 mRNA was translated in the absence (lanes 1 and 2) 
or presence 0ane 3) of dog pancreatic microsomes. The 
translation mixture was analysed by SDS-PAGE and visualised 
by autoradiography. Lanes 1 and 2 are the same except 
exposure time was respectively overnight and three days, lane 3 
corresponds to an overnight exposure time. (B) COS-7 cells 
were translated with HLUG25 cDNA, proteins were labelled 
with L-[35Slmethionine 72 h later and UDPGT was specifically 
immunoprecipitated. The immunoprecipitates were analysed by 
SDS-PAGE and visualised by autoradiography. Lanes 1 and 2
correspond respectively to cells being transfected with the 
expression vector including the HLUG25 cDNA in the correct 
and reverse orientation. The arrow indicates the expressed 
52 kDa protein. 
precipitated with this ant ibody appear to result 
f rom incorrect initiation o f  translation or f rom 
proteolytic degradation. They are likely to be 
artefacts o f  the in vitro system as they are not 
observed by in vivo expression in mammal ian cell 
cultures (fig.lB). 
The HLUG25 cDNA expressed in the mam- 
malian COS-7 cells allowed synthesis o f  a labelled 
immunoprecipitable glycopeptide of  52 kDa 
(fig. 1B, lane 1), corresponding to the matured and 
enzymatically active UDPGT isoform. 
3.2. Substrate specificity of the UDPGT expressed 
in COS-7 cells 
The transfection and expression of  the UDPGT 
cDNA in cell culture provided a stable source of  a 
catalytically active single enzyme for the study of  
its individual substrate specificity. 
Table 1 shows that the transferase synthesized 
f rom HLUG25 cDNA COS-7 cells effectively 
catalysed the glucuronidation of  hyodeoxycholic 
acid, whereas no UDPGT activity was detected in 
the control mock-transfected cells using this 
substrate. This radioact ive conjugate was 
hydrolysed by treatment with rat preputial /3- 
glucuronidase. The hydrolysis was specifically in- 
hibited by saccharo-l,4-1actone (not shown) in- 
dicating that this conjugate was a glucuronide. 
This bile acid has several potential sites o f  conjuga- 
tion. We tested other bile acids and steroids with 
different combinations o f  hydroxyl groups on the 
steroid nucleus in the 3, 6, 7, 12 and 17 positions. 
Human liver microsomes were able to 
glucuronidate the bile acids and steroid hormones 
tested under the conditions used (table 1). COS-7 
cells transfected with HLUG25 only expressed 
UDPGT activity towards hyodeoxycholic acid. 
However,  some of  the compounds used were 
glucuronidated at low rates by liver microsomes 
Table 1 
Catalytic activity of the expressed UDPGT in COS-7 cells 
UDPGT activity 
Human liver Mock HLUG25 
microsomes transfected COS-7 
(pmol/min COS-7 cells 
per mg cells (pmol/min 
protein) (pmol/min per mg 
per mg cell 
cell protein) 
protein) 
Hyodeoxycholic acid 449.0 ND 1.8 
Lithocholic acid 8.6 ND ND 
Ursodeoxycholic acid 2.5 ND ND 
Chenodeoxychoilc acid 5.0 ND ND 
Cholic acid ND ND ND 
Androsterone 98.3 ND ND 
Testosterone 39.1 ND ND 
Oestrone 12.7 ND ND 
ND, not detectable. Results how the mean values obtained 
using four hatches of transfected ceils and a single preparation 
of human liver microsomes 
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and it is likely that only androsterone glucuronida- 
tion would have been detected ue to the limits of 
sensitivity of the assay system. Therefore, we could 
not assess most of the bile acids as substrates for 
the expressed UDPGT. We found detectable 
UDPGT activities towards 1-naphthol and 
2-naphthol in the HLUG25 COS-7 cells at the same 
level as the activity in the control transfected cells 
(not shown). It thus appears that the UDPGT ac- 
tivity towards 1- and 2-naphthol was not due to the 
newly expressed UDPGT isoform. 
The 3tz-hydroxy position represents he primary 
site of conjugation of the steroids lacking 6a- 
hydroxyl group. Androsterone, which has been 
shown to be glucuronidated bya specific UDPGT 
isoenzyme conjugating 3a-steroids in rat and 
human [18,19], was not apparently a substrate for 
the expressed HLUG25. It has been shown that 
monohydroxylated bile acids could also form 
carboxyl-linked glucuronides [20]. However, it was 
recently demonstrated by gas chromatography/ 
mass spectrometry analysis that the glucuronides 
of hyodeoxycholic a id enzymaticaily s nthesized 
with microsomes of human liver and kidney were 
exclusively conjugated at the 6~-hydroxy position 
[6]. The hyodeoxycholate conjugate w s not alkali- 
labile after an overnight exposure to ammonia 
vapour [21], whereas bilirubin glucuronides were 
ammonia-lysed (not shown), suggesting that the 
bile acid glucuronide formed was not ester linked. 
Hyodeoxycholic acid is a secondary bile acid 
formed from hyocholic acid by bacterial 7er- 
dehydroxylation [22] or by 6a~-hydroxylation from 
lithocholic acid [23]. It is tempting to speculate 
that 6~-glucuronidation plays a major physiologi- 
cal role in conditions where 6~-hydroxylase activi- 
ty is highly expressed, like in the foetus, or when 
the biliary excretion of 3a-glucuronides of bile 
acids is impaired, as in cholestatic disease. The 
cloning and expression of a specific isoform 
catalysing the glucuronidation f 6~-bile acids, 
provides the appropriate probe for regulation 
studies and will help in particular to investigate 
whether or not a possible coupling of 6a- 
hydroxylation a d 6a-glucuronidation s an impor- 
tant detoxification process in man. 
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